BAILLIE GIFFORD & CO 13D and 13G filings for NovoCure Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-09 06:15 am Sale | 2023-10-31 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 5,095,777 4.770% | -3,768,065 (-42.51%) | Filing |
| 2023-01-23 10:49 am Sale | 2022-12-30 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 8,863,842 8.450% | -751,326 (-7.81%) | Filing |
| 2022-01-26 09:17 am Purchase | 2021-12-31 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 9,615,168 9.260% | 1,354,093 (+16.39%) | Filing |
| 2021-01-14 12:14 pm Purchase | 2020-12-31 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 8,261,075 8.120% | 252,093 (+3.15%) | Filing |